| 000 | 01677 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513214019.0 | ||
| 264 | 0 | _c20001025 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200006160-00034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerloff, M D | |
| 245 | 0 | 0 |
_aInduction of P-glycoprotein expression by HIV protease inhibitors in cell culture. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cJun 2000 |
||
| 300 |
_a1287-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAdenocarcinoma |
| 650 | 0 | 4 | _aCarbamates |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aColonic Neoplasms |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xpharmacology |
| 650 | 0 | 4 |
_aIvermectin _xpharmacology |
| 650 | 0 | 4 |
_aNelfinavir _xpharmacology |
| 650 | 0 | 4 |
_aRitonavir _xpharmacology |
| 650 | 0 | 4 |
_aSaquinavir _xpharmacology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 650 | 0 | 4 |
_aVinblastine _xpharmacology |
| 700 | 1 | _avon Moltke, L L | |
| 700 | 1 | _aFahey, J M | |
| 700 | 1 | _aDaily, J P | |
| 700 | 1 | _aGreenblatt, D J | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 14 _gno. 9 _gp. 1287-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200006160-00034 _zAvailable from publisher's website |
| 999 |
_c10844694 _d10844694 |
||